Integrative Modeling Strategies for Predicting Drug Toxicities at the eTOX Project
暂无分享,去创建一个
Ferran Sanz | Manuel Pastor | Floriane Montanari | Pau Carrió | Thomas Kleinöder | Luigi Capoferri | Daan P Geerke | Gerhard F Ecker | Oriol López | Derk P Kooi | Nico P E Vermeulen | Christof H Schwab | Tomasz Magdziarz
[1] Khaled Bouri,et al. Scientific and regulatory reasons for delay and denial of FDA approval of initial applications for new drugs, 2000-2012. , 2014, JAMA.
[2] Z Hruban,et al. Pulmonary and generalized lysosomal storage induced by amphiphilic drugs. , 1984, Environmental health perspectives.
[3] Ferran Sanz,et al. The eTOX Data-Sharing Project to Advance in Silico Drug-Induced Toxicity Prediction , 2014, International journal of molecular sciences.
[4] Kiyohiko Sugano,et al. Physicochemical and cell-based approach for early screening of phospholipidosis-inducing potential. , 2006, The Journal of toxicological sciences.
[5] Hugh A Barton,et al. Case study illustrating the WHO IPCS guidance on characterization and application of physiologically based pharmacokinetic models in risk assessment. , 2013, Regulatory toxicology and pharmacology : RTP.
[6] Chris Oostenbrink,et al. Improved ligand-protein binding affinity predictions using multiple binding modes. , 2010, Biophysical journal.
[7] Ferran Sanz,et al. eTOXlab, an open source modeling framework for implementing predictive models in production environments , 2015, Journal of Cheminformatics.
[8] Olivier Taboureau,et al. Virtual Screening and Prediction of Site of Metabolism for Cytochrome P450 1A2 Ligands , 2009, J. Chem. Inf. Model..
[9] Araz Jakalian,et al. Fast, efficient generation of high‐quality atomic charges. AM1‐BCC model: I. Method , 2000 .
[10] Pantelis Sopasakis,et al. Collaborative development of predictive toxicology applications , 2010, J. Cheminformatics.
[11] G. Cruciani,et al. Generating Optimal Linear PLS Estimations (GOLPE): An Advanced Chemometric Tool for Handling 3D‐QSAR Problems , 1993 .
[12] Nigel Greene,et al. Analysis of Pfizer compounds in EPA's ToxCast chemicals-assay space. , 2014, Chemical research in toxicology.
[13] S. Pickett,et al. GRid-INdependent descriptors (GRIND): a novel class of alignment-independent three-dimensional molecular descriptors. , 2000, Journal of medicinal chemistry.
[14] Manuel Pastor,et al. Development and Validation of AMANDA, a New Algorithm for Selecting Highly Relevant Regions in Molecular Interaction Fields , 2008, J. Chem. Inf. Model..
[15] J. Aqvist,et al. A new method for predicting binding affinity in computer-aided drug design. , 1994, Protein engineering.
[16] J. Schellens,et al. Increased oral bioavailability of topotecan in combination with the breast cancer resistance protein and P-glycoprotein inhibitor GF120918. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] Floriane Montanari,et al. BCRP Inhibition: from Data Collection to Ligand‐Based Modeling , 2014, Molecular informatics.
[18] Ruili Huang,et al. The Tox21 robotic platform for the assessment of environmental chemicals--from vision to reality. , 2013, Drug discovery today.
[19] M. Cases,et al. Inroads to Predict in Vivo Toxicology—An Introduction to the eTOX Project , 2012, International journal of molecular sciences.
[20] Ferran Sanz,et al. A Multiscale Simulation System for the Prediction of Drug-Induced Cardiotoxicity , 2011, J. Chem. Inf. Model..
[21] Thorsten Meinl,et al. KNIME: The Konstanz Information Miner , 2007, GfKl.
[22] Ferran Sanz,et al. Applicability Domain Analysis (ADAN): A Robust Method for Assessing the Reliability of Drug Property Predictions , 2014, J. Chem. Inf. Model..
[23] Akbar Nayeem,et al. A 3D-QSAR model for CYP2D6 inhibition in the aryloxypropanolamine series. , 2005, Bioorganic & medicinal chemistry letters.
[24] Chris Oostenbrink,et al. CYP 2D6 Binding Affinity Predictions Using Multiple Ligand and Protein Conformations , 2013, International journal of molecular sciences.
[25] Antti Poso,et al. Predictive three-dimensional quantitative structure-activity relationship of cytochrome P450 1A2 inhibitors. , 2005, Journal of medicinal chemistry.
[26] Gaël Varoquaux,et al. Scikit-learn: Machine Learning in Python , 2011, J. Mach. Learn. Res..
[27] Olga Tcheremenskaia,et al. New perspectives in toxicological information management, and the role of ISSTOX databases in assessing chemical mutagenicity and carcinogenicity. , 2013, Mutagenesis.
[28] Ralph Kühne,et al. The OSIRIS Weight of Evidence approach: ITS for the endpoints repeated-dose toxicity (RepDose ITS). , 2013, Regulatory toxicology and pharmacology : RTP.
[29] J. Kramer,et al. The application of discovery toxicology and pathology towards the design of safer pharmaceutical lead candidates , 2007, Nature Reviews Drug Discovery.
[30] René Meier,et al. ParaDockS: A Framework for Molecular Docking with Population-Based Metaheuristics , 2010, J. Chem. Inf. Model..
[31] Mathieu Vinken,et al. The adverse outcome pathway concept: a pragmatic tool in toxicology. , 2013, Toxicology.
[32] Carsten Kutzner,et al. GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation. , 2008, Journal of chemical theory and computation.
[33] J. Sutherland,et al. A comparison of methods for modeling quantitative structure-activity relationships. , 2004, Journal of medicinal chemistry.
[34] Loriano Storchi,et al. New and Original pKa Prediction Method Using Grid Molecular Interaction Fields , 2007, J. Chem. Inf. Model..
[35] David M. Reif,et al. Update on EPA's ToxCast program: providing high throughput decision support tools for chemical risk management. , 2012, Chemical research in toxicology.
[36] Jozef Hritz,et al. Impact of plasticity and flexibility on docking results for cytochrome P450 2D6: a combined approach of molecular dynamics and ligand docking. , 2008, Journal of medicinal chemistry.
[37] Annette Kopp-Schneider,et al. Design of a testing strategy using non-animal based test methods: lessons learnt from the ACuteTox project. , 2013, Toxicology in vitro : an international journal published in association with BIBRA.
[38] David Raunig,et al. In vitro drug interactions of cytochrome p450: an evaluation of fluorogenic to conventional substrates. , 2003, Drug metabolism and disposition: the biological fate of chemicals.
[39] Daan P. Geerke,et al. Towards Automated Binding Affinity Prediction Using an Iterative Linear Interaction Energy Approach , 2014, International journal of molecular sciences.
[40] Wim F Vranken,et al. ACPYPE - AnteChamber PYthon Parser interfacE , 2012, BMC Research Notes.
[41] Naomi L Kruhlak,et al. Development of a Phospholipidosis Database and Predictive Quantitative Structure-Activity Relationship (QSAR) Models , 2008, Toxicology mechanisms and methods.
[42] Loriano Storchi,et al. Tautomer Enumeration and Stability Prediction for Virtual Screening on Large Chemical Databases , 2009, J. Chem. Inf. Model..